149 related articles for article (PubMed ID: 35836883)
21. Smilax glabra Roxb. flavonoids protect against pathological cardiac hypertrophy by inhibiting the Raf/MEK/ERK pathway: In vivo and in vitro studies.
Fu D; Zhou J; Xu S; Tu J; Cai Y; Liu J; Cai Z; Wang D
J Ethnopharmacol; 2022 Jun; 292():115213. PubMed ID: 35331878
[TBL] [Abstract][Full Text] [Related]
22. Hydrogen sulfide mitigates homocysteine-mediated pathological remodeling by inducing miR-133a in cardiomyocytes.
Kesherwani V; Nandi SS; Sharawat SK; Shahshahan HR; Mishra PK
Mol Cell Biochem; 2015 Jun; 404(1-2):241-50. PubMed ID: 25763715
[TBL] [Abstract][Full Text] [Related]
23. Cardiac Gq Receptors and Calcineurin Activation Are Not Required for the Hypertrophic Response to Mechanical Left Ventricular Pressure Overload.
Yu ZY; Gong H; Wu J; Dai Y; Kesteven SH; Fatkin D; Martinac B; Graham RM; Feneley MP
Front Cell Dev Biol; 2021; 9():639509. PubMed ID: 33659256
[TBL] [Abstract][Full Text] [Related]
24. Ca
Baier MJ; Klatt S; Hammer KP; Maier LS; Rokita AG
J Mol Cell Cardiol; 2020 Jan; 138():212-221. PubMed ID: 31836540
[TBL] [Abstract][Full Text] [Related]
25. Increased oxidative stress in the nucleus caused by Nox4 mediates oxidation of HDAC4 and cardiac hypertrophy.
Matsushima S; Kuroda J; Ago T; Zhai P; Park JY; Xie LH; Tian B; Sadoshima J
Circ Res; 2013 Feb; 112(4):651-63. PubMed ID: 23271793
[TBL] [Abstract][Full Text] [Related]
26. Isorhynchophylline enhances Nrf2 and inhibits MAPK pathway in cardiac hypertrophy.
Zhang Y; Cui Y; Dai S; Deng W; Wang H; Qin W; Yang H; Liu H; Yue J; Wu D; Wang J; Guo H
Naunyn Schmiedebergs Arch Pharmacol; 2020 Feb; 393(2):203-212. PubMed ID: 31489470
[TBL] [Abstract][Full Text] [Related]
27. Novel PGC-1
Zhang B; Tan Y; Zhang Z; Feng P; Ding W; Wang Q; Liang H; Duan W; Wang X; Yu S; Liu J; Yi D; Sun Y; Yi W
Oxid Med Cell Longev; 2020; 2020():9187065. PubMed ID: 33425220
[TBL] [Abstract][Full Text] [Related]
28. CaMKIIδC Drives Early Adaptive Ca
Ljubojevic-Holzer S; Herren AW; Djalinac N; Voglhuber J; Morotti S; Holzer M; Wood BM; Abdellatif M; Matzer I; Sacherer M; Radulovic S; Wallner M; Ivanov M; Wagner S; Sossalla S; von Lewinski D; Pieske B; Brown JH; Sedej S; Bossuyt J; Bers DM
Circ Res; 2020 Oct; 127(9):1159-1178. PubMed ID: 32821022
[TBL] [Abstract][Full Text] [Related]
29. Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction.
Zhao L; Cheng G; Jin R; Afzal MR; Samanta A; Xuan YT; Girgis M; Elias HK; Zhu Y; Davani A; Yang Y; Chen X; Ye S; Wang OL; Chen L; Hauptman J; Vincent RJ; Dawn B
Circ Res; 2016 Jun; 118(12):1918-1929. PubMed ID: 27126808
[TBL] [Abstract][Full Text] [Related]
30. CaMKIIδ meditates phenylephrine induced cardiomyocyte hypertrophy through store-operated Ca
Ji Y; Guo X; Zhang Z; Huang Z; Zhu J; Chen QH; Gui L
Cardiovasc Pathol; 2017; 27():9-17. PubMed ID: 27940402
[TBL] [Abstract][Full Text] [Related]
31. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
[TBL] [Abstract][Full Text] [Related]
32. Activation of transient receptor potential vanilloid 4 is involved in pressure overload-induced cardiac hypertrophy.
Zou Y; Zhang M; Wu Q; Zhao N; Chen M; Yang C; Du Y; Han B
Elife; 2022 Jun; 11():. PubMed ID: 35731090
[TBL] [Abstract][Full Text] [Related]
33. Annexin A7 deficiency potentiates cardiac NFAT activity promoting hypertrophic signaling.
Voelkl J; Alesutan I; Pakladok T; Viereck R; Feger M; Mia S; Schönberger T; Noegel AA; Gawaz M; Lang F
Biochem Biophys Res Commun; 2014 Feb; 445(1):244-9. PubMed ID: 24508799
[TBL] [Abstract][Full Text] [Related]
34. A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin.
Liu W; Zi M; Tsui H; Chowdhury SK; Zeef L; Meng QJ; Travis M; Prehar S; Berry A; Hanley NA; Neyses L; Xiao RP; Oceandy D; Ke Y; Solaro RJ; Cartwright EJ; Lei M; Wang X
Circ Heart Fail; 2013 Jul; 6(4):833-44. PubMed ID: 23753531
[TBL] [Abstract][Full Text] [Related]
35. Enhanced hypertrophy in ob/ob mice due to an impairment in expression of atrial natriuretic peptide.
Mascareno E; Beckles D; Dhar-Mascareno M; Siddiqui MA
Vascul Pharmacol; 2009; 51(2-3):198-204. PubMed ID: 19560554
[TBL] [Abstract][Full Text] [Related]
36. CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy.
Backs J; Song K; Bezprozvannaya S; Chang S; Olson EN
J Clin Invest; 2006 Jul; 116(7):1853-64. PubMed ID: 16767219
[TBL] [Abstract][Full Text] [Related]
37. MiR-218 affects hypertrophic differentiation of human mesenchymal stromal cells during chondrogenesis via targeting RUNX2, MEF2C, and COL10A1.
Melnik S; Gabler J; Dreher SI; Hecht N; Hofmann N; Großner T; Richter W
Stem Cell Res Ther; 2020 Dec; 11(1):532. PubMed ID: 33303006
[TBL] [Abstract][Full Text] [Related]
38. Distinct roles of calmodulin and Ca
Wang S; Li J; Liu Y; Zhang J; Zheng X; Sun X; Lei S; Kang Z; Chen X; Lei M; Hu H; Zeng X; Hao L
Biochem Biophys Res Commun; 2020 Jun; 526(4):960-966. PubMed ID: 32303334
[TBL] [Abstract][Full Text] [Related]
39. Cacao Bean Polyphenols Inhibit Cardiac Hypertrophy and Systolic Dysfunction in Pressure Overload-induced Heart Failure Model Mice.
Sari N; Katanasaka Y; Honda H; Miyazaki Y; Sunagawa Y; Funamoto M; Shimizu K; Shimizu S; Wada H; Hasegawa K; Morimoto T
Planta Med; 2020 Nov; 86(17):1304-1312. PubMed ID: 32645737
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological inhibition of Hippo pathway, with the novel kinase inhibitor XMU-MP-1, protects the heart against adverse effects during pressure overload.
Triastuti E; Nugroho AB; Zi M; Prehar S; Kohar YS; Bui TA; Stafford N; Cartwright EJ; Abraham S; Oceandy D
Br J Pharmacol; 2019 Oct; 176(20):3956-3971. PubMed ID: 31328787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
